RCKT insiders were on both sides of the trade this year. Buys came to roughly $34,000 (one buyer), sales to $979,000 (six sellers).
Bjork Elisabeth (Director) made the biggest buy, worth around $34,000.
Zooming out by quarter: 5 quarters in a row of net selling by insiders. Insiders bought in 3 of the last 7 full quarters. 180 investment managers listed RCKT in their latest 13F filings (Q2 2026); funds were split between buying and selling.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | Wilson Martin | Executive Officer | Sell | 75,364 | $3.40 | $256K | SEC |
| Aug 20, 2026 | Wilson Martin | Executive Officer | Sell | 631 | $3.38 | $2K | SEC |
| Aug 20, 2026 | Shah Gaurav | CEO | Sell | 2,293 | $3.38 | $8K | SEC |
| Aug 17, 2026 | Shah Gaurav | CEO | Sell | 2,837 | $3.38 | $10K | SEC |
| Aug 17, 2026 | Wilson Martin | Executive Officer | Sell | 3,493 | $3.38 | $12K | SEC |
| Aug 13, 2026 | Stevens Christopher James | COO | Sell | 36,658 | $3.50 | $128K | SEC |
| Aug 13, 2026 | Chaudhuri Sarbani | Officer | Sell | 4,701 | $3.50 | $16K | SEC |
| May 26, 2026 | Shah Gaurav | CEO | Sell | 55,684 | $3.09 | $172K | SEC |
| May 21, 2026 | Shah Gaurav | CEO | Sell | 2,409 | $3.01 | $7K | SEC |
| May 21, 2026 | Wilson Martin | Executive Officer | Sell | 662 | $3.01 | $2K | SEC |
| May 21, 2026 | Militello John | Officer | Sell | 384 | $3.01 | $1K | SEC |
| May 14, 2026 | Wilson Martin | Executive Officer | Sell | 3,361 | $3.61 | $12K | SEC |
| May 14, 2026 | Shah Gaurav | CEO | Sell | 2,728 | $3.61 | $10K | SEC |
| May 14, 2026 | Militello John | Officer | Sell | 855 | $3.61 | $3K | SEC |
| May 11, 2026 | Chaudhuri Sarbani | Officer | Sell | 17,650 | $3.84 | $68K | SEC |
In the last 12 months Rocket Pharmaceuticals, Inc. insiders made open-market purchases worth about $34,000 and sales worth about $979,000. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in RCKT was filed on 2026-09-15.
180 investment managers reported holding RCKT in SEC Form 13F filings for Q2 2026.
No congressional trades in RCKT were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).